ADMA BIOLOGICS, INC. Accrued Liabilities, Current
ADMA BIOLOGICS, INC. (ADMA) had Accrued Liabilities, Current of $8.37 million as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2021-03-25
- 2020-12-31: Accrued Liabilities, Current $8.37M.
- 2020-09-30: Accrued Liabilities, Current $8.07M.
- 2020-06-30: Accrued Liabilities, Current $5.62M.
- 2020-03-31: Accrued Liabilities, Current $4.42M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2020-12-31 | $8.37M 10-K · filed 2021-03-25 | |
| 2020-09-30 | $8.07M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $5.62M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $4.42M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $4.48M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $4.76M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $2.97M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.51M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $3.55M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $4.45M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $3.64M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $3.58M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $3.38M 10-K · filed 2019-03-13 | $3.32M 10-K · filed 2018-03-29 |
| 2017-09-30 | $3.86M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $4.14M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $2.22M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $2.39M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $1.82M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.60M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $1.66M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $1.97M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $1.95M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $1.46M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $1.80M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $2.22M 10-K · filed 2016-03-23 | |
| 2014-09-30 | $1.51M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.23M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.35M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $823.55K 10-K · filed 2015-03-09 | |
| 2013-09-30 | $911.13K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $753.14K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $676.67K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $747.08K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $502.59K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $204.59K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $508.25K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $537.71K 10-K · filed 2013-03-06 | $5.31K 10-Q · filed 2012-02-01 |
| 2011-09-30 | $9.81K 10-Q · filed 2011-10-28 | |
| 2011-06-30 | $9.82K 10-Q · filed 2012-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |